検索結果 - Augusta Ortolan
- 検索結果 1 - 12 結果 / 12
-
1
-
2
-
3
-
4
Work productivity is associated with disease activity and functional ability in Italian patients with early axial spondyloarthritis: an observational study from the SPACE cohort 著者: Manouk de Hooge, Roberta Ramonda, Mariagrazia Lorenzin, Paola Frallonardo, Leonardo Punzi, Augusta Ortolan, Andrea Doria
出版事項 2016Artigo -
5
Influence of tumor necrosis factor α inhibitors on testicular function and semen in spondyloarthritis patients 著者: Roberta Ramonda, Carlo Foresta, Augusta Ortolan, Alessandro Bertoldo, Francesca Oliviero, Mariagrazia Lorenzin, Damiano Pizzol, Leonardo Punzi, Andrea Garolla
出版事項 2013Artigo -
6
Response to: Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update" by Ramiro<i>et al</i> 著者: Sofía Ramiro, Elena Nikiphorou, Alexandre Sepriano, Augusta Ortolan, Casper Webers, Xenofon Baraliakos, Robert Landewé, Désirée van der Heijde
出版事項 2023Carta -
7
Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the mana... 著者: Augusta Ortolan, Casper Webers, Alexandre Sepriano, Louise Falzon, Xenofon Baraliakos, Robert Landewé, Sofía Ramiro, Désirée van der Heijde, Elena Nikiphorou
出版事項 2022Revisão -
8
Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis 著者: Casper Webers, Augusta Ortolan, Alexandre Sepriano, Louise Falzon, Xenofon Baraliakos, Robert Landewé, Sofía Ramiro, Désirée van der Heijde, Elena Nikiphorou
出版事項 2022Revisão -
9
Are gender-specific approaches needed in diagnosing early axial spondyloarthritis? Data from the SPondyloArthritis Caught Early cohort 著者: Augusta Ortolan, M. van Lunteren, Sofía Ramiro, Roberta Ramonda, Robert Landewé, Hanne Dagfinrud, L. Jacobsson, Désirée van der Heijde, F. van Gaalen
出版事項 2018Artigo -
10
Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study 著者: Roberta Ramonda, Mariagrazia Lorenzin, Antonio Carriero, Maria Sole Chimenti, Raffaele Scarpa, Antonio Marchesoni, Ennio Lubrano, Carlo Salvarani, Alberto Cauli, Angelo Semeraro, Leonardo Santo, Augusta Ortolan, Andrea Doria, Elena Fracassi, Giulia Virelli, Marco Masia, R. Fanizzi, Elisa Visalli, Giorgio Amato, Antonio Carletto, Rosario Foti
出版事項 2021Artigo -
11
SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients 著者: Margherita Zen, Enrico Fuzzi, D. Astorri, Francesca Saccon, Roberto Padoan, Luana Ienna, Giacomo Cozzi, Roberto Depascale, Elisabetta Zanatta, Michela Gasparotto, Francesco Benvenuti, Sara Bindoli, Mariele Gatto, Mara Felicetti, Augusta Ortolan, Debora Campaniello, Maddalena Larosa, Mariagrazia Lorenzin, Roberta Ramonda, Paolo Sfriso, Franco Schiavon, Leonardo Iaccarino, Andrea Doria
出版事項 2020Artigo -
12
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update 著者: Sofía Ramiro, Elena Nikiphorou, Alexandre Sepriano, Augusta Ortolan, Casper Webers, Xenofon Baraliakos, Robert Landewé, Filip Van den Bosch, B. Boteva, Ann Bremander, Philippe Carron, Adrian Ciurea, F. van Gaalen, Pál Géher, Lianne S. Gensler, Josef Hermann, Manouk de Hooge, Markéta Hušáková, Uta Kiltz, Clementina López‐Medina, Pedro Machado, Helena Marzo‐Ortega, Anna Moltó, Victoria Navarro‐Compán, Michael J. Nissen, Fernando Pimentel-Santos, Denis Poddubnyy, Fabian Proft, Martín Rudwaleit, Mark Telkman, Sizheng Steven Zhao, Nelly Ziadé, Désirée van der Heijde
出版事項 2022Artigo
関連主題
Internal medicine
Medicine
Ankylosing spondylitis
Disease
Physical therapy
Psoriatic arthritis
Axial spondyloarthritis
Sacroiliitis
BASDAI
Cohort
Rheumatology
Secukinumab
Tumor necrosis factor alpha
Adverse effect
BASFI
Coronavirus disease 2019 (COVID-19)
Discontinuation
Erythrocyte sedimentation rate
Etanercept
Infectious disease (medical specialty)
Infliximab
Observational study
Pathology
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Surgery
Virology
2019-20 coronavirus outbreak
Absenteeism
Adalimumab
Alternative medicine